Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06549504
PHASE1

Bioequivalence Study of AG2202

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the human bioequivalence of AG2202T and AG2202R.

Official title: An Open-label, Randomized, Fasting, Single, Oral Administration, Group 2, Stage 2, Cross-over Bioequivalence Study of AG2202 in Healthy Volunteers

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

34

Start Date

2024-08

Completion Date

2024-09

Last Updated

2024-08-14

Healthy Volunteers

Yes

Interventions

DRUG

AG2202T

AG2202T Single-dose

DRUG

AG2202R

AG2202R Single-dose